期刊文献+

孤立性肺结节良恶性鉴别的相关因素分析 被引量:1

下载PDF
导出
摘要 目的评价孤立性肺结节(SPN)良恶性鉴别的相关因素并探讨其诊断与治疗.方法:我院及江苏省肿瘤医院行手术治疗101例孤立性肺结节患者,采用单因素方差分析患者的年龄、性别、吸烟状况、恶性肿瘤家族史、结节大小、癌胚抗原(CEA)、饮酒史、影像学表现和结节部位等因素与孤立性肺结节良恶性病变之间的关系,采用多因素logistic回归分析孤立性肺结节恶性可能的相关危险因素.结果:单因素分析结果表明,年龄(P =0.001)、吸烟指数(P =0.031)、结节大小(P =0.000)、恶性肿瘤家族史(P=0.036)、影像学表现(P=0.001)与结节病变的良恶性均有明显的关系.多因素logistic回归分析显示,患者年龄(OR值=4.862)、结节大小(OR值=2.879)、影像学表现(OR值=4.956)与孤立性肺结节的良恶性显著相关.结论:对于孤立性肺结节患者,年龄、结节大小、影像学表现、恶性肿瘤家族史和吸烟史,尤其是前三者可作为评估孤立性肺结节良恶性病变的危险因素.
出处 《世界中医药》 CAS 2015年第A02期888-889,共2页 World Chinese Medicine
  • 相关文献

参考文献11

  • 1GouldMK, Fletcher J , IannettoniMD, et al. Evaluation of patientswith pulmonary nodules: when is it lung cancer:ACCP evidence - basedclinical p ractice guidelines ( 2nd edition) [J]. Chest, 2007, 132 (3 Supp l) :108S-130S1.
  • 2鄂林宁,马大庆.肺内小结节的影像诊断和处理[J].中华放射学杂志,2009,43(3):332-334. 被引量:33
  • 3Albert RH, Russell JJ. Evaluation of the solitary pulmonarynodule[J].Am Fam Physician, 2009, 80 ( 8) : 827-831.
  • 4Winer-Muram HT. The solitary pulmonary nodule[J].Radiology,2006, 239(1):34-4.
  • 5McCormack PM, Ginsberg, Bain MS,et al. Accuracy of lung imagingin metastases with implication for the role of thoracoscopy[J].Ann ThoracSurg,1993,56(4):863-865.
  • 6尚立群,李辉,姚松朝,张章渝,王田贵,李学昌.209例肺内单发球形病变的诊治[J].中华胸心血管外科杂志,2000,16(6):360-360. 被引量:31
  • 7Cummings, SR, Lillington, GA, Richard, RJ .Managing solitarypulmonary nodules: the choice of strategy is a “close call [J]. Am Rev RespirDis, 1986, 134, 453-460 .
  • 8Gould, MK, Sanders, GD, Barnett, PG, et al Cost-effectiveness ofalternative management strategies for patients with solitary pulmonarynodules[J].Ann Intern Med 2003; 138, 724-735.
  • 9Liptay MJ. Solitary pulmonary nodule: treatment options[J].Chest,1999,116(6 Suppl):517S-518S.
  • 10何建行,杨运有,张镜芳.肺部微小结节的微创伤诊治[J].中华胸心血管外科杂志,2000,16(3):144-146. 被引量:51

二级参考文献36

  • 1吴晓华,马大庆,张忠嘉,冀景玲,张岩松.多层螺旋CT胸部低剂量扫描发现肺结节的临床研究[J].中华放射学杂志,2004,38(7):767-770. 被引量:86
  • 2王俊,陈鸿义,崔英杰,刘桐林,李剑峰,李曰民.胸腔镜手术在肺癌诊断和治疗中的作用和地位[J].中华外科杂志,1996,34(2):79-81. 被引量:57
  • 3Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 2008, 246:697-722.
  • 4Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidline (2rid ed). Chest, 2007, 132(3 Suppl) :94S-107S.
  • 5Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AIR, 2007, 188:57-68.
  • 6Winer-Muram HT. The solitary pulmonary nodule. Radiology, 2006, 239:34-49.
  • 7Park CM, Goo JM, Lee HJ, et al. Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up. Radiographics, 2007, 27:391-408.
  • 8Yoon HE, Fukuhara K, Michiura T, et al. Pulmonary nodules 10 mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy. Jpn J Thorac Cardiovasc Surg, 2005, 53:22-28.
  • 9Kim HY, Shim YM, Lee KS, et al. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology, 2007, 245:267-275.
  • 10Oda S, Awai K, Liu D, et al. Ground-glass opacities on thinsection helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasiz. AJR, 2008, 190 : 1363-1368.

共引文献127

同被引文献17

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部